VANCOUVER, British Columbia, Aug. 30, 2024 (GLOBE NEWSWIRE) — AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “Avricore”) today announces that the Company’s board of directors has approved the granting of stock options (the “Options”) exercisable for a total of 3,361,000 common shares to its directors, officers, employees and consultants at an exercise price of […]
Category Archives: Pr Newswire
GUANGZHOU, China, Aug. 31, 2024 /PRNewswire/ — Viomi Technology Co., Ltd (“Viomi” or the “Company”) (NASDAQ: VIOT), a leading technology company for home water solutions in China, today announced that all the conditions precedent to the divestment of certain businesses and assets related to IoT@Home portfolio products, as previously announced on July 19, 2024 (the “Transaction“), […]
Three-Day Mega Event Concludes, Attracting 300 exhibitors from across the world, 100000 Footfalls, 1000 Speakers MUMBAI, India, Aug. 31, 2024 /PRNewswire/ — India’s Union Minister of Commerce and Industry Mr. Piyush Goyal said on Friday that the Indian fintech ecosystem had turned into a hotbed for innovation. Addressing the Global Fintech Fest 2024 in Mumbai, he said, “As […]
Pr Newswire
Vision Sensing Acquisition Corp. Announces Intention to Extend the Period to Consummate Its Initial Business Combination to October 3, 2024
31
Aug
Aug
NEW YORK, Aug. 30, 2024 (GLOBE NEWSWIRE) — Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the “Company”) a special purpose acquisition company, announced today that it has notified Continental Stock Transfer & Trust Company that it intends to extend the date by which the Company must consummate its initial business combination from September 3, […]
Pr Newswire
Aptose Receives $10 Million Through a Facility Agreement with Hanmi; Negotiating Future Collaboration Agreement with Hanmi to Jointly Develop Tuspetinib
31
Aug
Aug
Proceeds to be used for development of lead compound tuspetinib in combination therapy as frontline treatment for newly diagnosed AML patients SAN DIEGO and TORONTO, Aug. 30, 2024 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing tuspetinib, a highly differentiated oral kinase inhibitor […]
31
Aug
Aug
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES BOCA RATON, Fla., Aug. 30, 2024 (GLOBE NEWSWIRE) — Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, announced it has filed a preliminary short form base shelf prospectus with the securities […]
31
Aug
Aug
August 30, 2024 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”)Receipt of Nasdaq Delisting Determination Plans to Appeal Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), an acquisition-focused clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, announced today that on August 27, 2024, it received a Staff Determination letter […]
31
Aug
Aug
All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, Aug. 30, 2024 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”) a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for the second quarter ending June 30, 2024, and provides […]
NEW YORK, Aug. 31, 2024 /PRNewswire/ — Aquaron Acquisition Corp. (NASDAQ: AQU, the “Company“), a special purpose acquisition company, announced today that it received a written notice (the “Letter“) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq“) indicating that, because the Company has not regained compliance with Listing Rule 5550(a)(3) (the […]
BEIJING, Aug. 31, 2024 /PRNewswire/ — TuanChe Limited (“TuanChe,” “Company,” “we” or “our”) (NASDAQ: TC), a leading integrated automotive marketplace in China, today announced its unaudited financial results for the six months ended June 30, 2024. Key First Half 2024 Financial and Operating Metrics Net revenues were RMB32.3 million (US$4.4 million). Gross profit was RMB22.4 […]